NEW .5 PRODUCT for Foot & Ankle applications
Whether you are addressing damaged tissue in articular cartilage, Achilles tendon or Plantar Fascia attachment points, or surrounding soft tissue; consider Wharton’s jelly for Connective Tissue Supplementation to repair or replace the damaged tissue with new healthy connective tissue.
WHARTON’S JELLY ALLOGRAFT
Wharton’s jelly (WJ) allografts consist of human umbilical cord tissue that is disassociated, suspended in saline, and cryopreserved. Their primary function is to provide cushioning and structural support and replace missing or damaged tissue in the patient, applied directly to the defect or injured area in soft tissues. They are applied via syringe and are typically used in ligament, muscle, or cartilage tears.
DATA
- Ongoing Retrospective Repository Data
- Data Collection Protocol Approved by the Institute of Regenerative and Cellular Medicine (IRB)
This data is based on a sample of 99 patients with various connective tissue defects of the legs, feet, and ankles from 27 different clinics enrolled in our observational study. There are 61 males and 38 females, aged 36 to 95. Ninety days after the Wharton’s jelly application, patients reported a 32% improvement in NPRS (current pain) and a 29% overall WOMAC improvement (pain/ stiffness/ function).
CryoText Product Information
For more information about our Cryotext product, visit the link below.
Pricing and PLACING AN order
For pricing or to place an order, login or setup an account to get immediate access to our MEDNGINE platform.
DON’t HESITATE TO REACH OUT.
If you have any further questions, please contact us. We look forward to speaking with you!